In the Systolic Blood Pressure Intervention Trial (SPRINT), adults at high risk for cardiovascular disease who received intensive systolic blood-pressure control (target, <120 mm Hg) had significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results